Global Equity Briefing

Global Equity Briefing

Home
Start Here
Portfolio
Deep Dives
Investment Cases
Fintech
AI
IREN
Nebius
DLocal
Zeta
Nu
Grab
Emerging Markets
Briefings
For Free Members
Archive
About
SanDisk Investment Thesis!
Transition from cyclical commodity to high-value AI infrastructure!
Feb 18
Seat-based SaaS is Dead! What Comes After?
6-point checklist to survive the SaaS Apocalypse.
Feb 12 • Ray Myers
Is Novo Nordisk a BUY?
Novo Nordisk. Equity Research! Part 3/3
Feb 10 • Ray Myers
Here is what I am BUYING right now!
What to do during this pullback.
Feb 8 • Ray Myers
Long IREN!
Updated 2030 Valuation Model!
Feb 7 • Ray Myers
Here is why IREN is down 50%.
Q4 2025 Review!
Feb 6 • Ray Myers
Blood in the Streets!
Novo Nordisk. Equity Research! Part 2/3
Feb 4 • Ray Myers
January 2026 Portfolio Review!
Weak start of the year!
Feb 1 • Ray Myers

January 2026

How Ozempic Transformed Novo Nordisk!
Novo Nordisk. Equity Research! Part 1/3
Jan 28 • Ray Myers
Why Dilution is Not Always Bad!
Investing Basics #7
Jan 26 • Ray Myers
SoFi Investment Thesis: Part 2!
Loan Platform Business, Crypto and SofiUSD Stablecoin.
Jan 22 • Ray Myers
UiPath Investment Thesis!
From SaaS to Agentic AI!
Jan 20 • Ray Myers
© 2026 Ray Myers · Privacy ∙ Terms ∙ Collection notice
Start your SubstackGet the app
Substack is the home for great culture